MNPR (STOCKS)
Monopar Therapeutics Inc. Common Stock
$59.240000
-0.150000 (-0.25%)
Prev close: $59.390000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Chandler Drew Robinson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $395.94M
- Employees
- 16
- P/E (TTM)
- -17.23
- P/B (TTM)
- 2.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
14
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.48 | $-0.44 | -0.0414 | -9.44% |
|
Jun 2025 (Q2)
|
$-0.35 | $-0.48 | +0.1314 | +27.30% |
|
Mar 2025 (Q1)
|
$-0.38 | $-0.69 | +0.3136 | +45.21% |
|
Dec 2024 (Q4)
|
$-2.75 | $-0.43 | -2.3216 | -541.92% |